---
schema_version: "secwatch.filing_event.v1"
accession: "0001021771-25-000079"
form_type: "8-K"
ticker: "BRTX"
cik: "0001505497"
company_name: "BioRestorative Therapies, Inc."
filed_at: "2025-05-14T23:59:59+00:00"
generated_at: "2026-05-21T08:29:38.499855+00:00"
event_type: "earnings"
sentiment: "neutral"
materiality_score: 0.3
calibrated_materiality_score: 0.3
confidence: "low"
source: SEC EDGAR
---

# BioRestorative Therapies issues Q1 2025 results press release; financial details not available

## Summary
- Company announced Q1 2025 financial results and business update on May 14, 2025.
- Press release references a conference call to discuss results, but specific figures are not included in the filing.
- No EPS, revenue, or segment data were disclosed in the submitted Form 8-K exhibits.

## SEC filing metadata
- accession: 0001021771-25-000079
- form_type: 8-K
- ticker: BRTX
- cik: 0001505497
- company_name: BioRestorative Therapies, Inc.
- filed_at: 2025-05-14T23:59:59+00:00
- event_type: earnings
- sentiment: neutral
- materiality_score: 0.3
- calibrated_materiality_score: 0.3
- confidence: low
- sec_items: 2.02, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1505497/000102177125000079/0001021771-25-000079-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1505497/000102177125000079/k51425.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001021771-25-000079
- JSON: https://secwatch.observer/filing/0001021771-25-000079.json
- Plain text: https://secwatch.observer/filing/0001021771-25-000079.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.